Review Article| Volume 37, ISSUE 4, P855-867, December 2017

Paroxysmal Nocturnal Hemoglobinuria Assessment by Flow Cytometric Analysis

Published:September 26, 2017DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rosse W.F.
        • Ware R.E.
        The molecular basis of paroxysmal nocturnal hemoglobinuria.
        Blood. 1995; 86: 3277-3286
        • Hillmen P.
        • Lewis S.M.
        • Bessler M.
        • et al.
        Natural history of paroxysmal nocturnal hemoglobinuria.
        N Engl J Med. 1995; 333: 1253-1258
        • Varela J.C.
        • Brodsky R.A.
        Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
        Expert Rev Clin Immunol. 2013; 9: 1113-1124
        • Parker C.J.
        Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.
        Hematol Oncol Clin North Am. 2009; 23: 333-346
        • Scheinberg P.
        • Marte M.
        • Nunez O.
        • et al.
        Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
        Haematologica. 2010; 95: 1075-1080
        • Borowitz M.J.
        • Craig F.E.
        • Digiuseppe J.A.
        • et al.
        Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.
        Cytometry B Clin Cytom. 2010; 78: 211-230
        • Parker C.
        • Omine M.
        • Richards S.
        • et al.
        Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
        Blood. 2005; 106: 3699-3709
        • van der Schoot C.E.
        • Huizinga T.W.
        • van 't Veer-Korthof E.T.
        • et al.
        Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay.
        Blood. 1990; 76: 1853-1859
        • Sutherland D.R.
        • Kuek N.
        • Davidson J.
        • et al.
        Diagnosing PNH with FLAER and multiparameter flow cytometry.
        Cytometry B Clin Cytom. 2007; 72: 167-177
        • Sutherland D.R.
        • Keeney M.
        • Illingworth A.
        Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry.
        Cytometry B Clin Cytom. 2012; 82: 195-208
        • Sutherland D.R.
        • Kuek N.
        • Azcona-Olivera J.
        • et al.
        Use of a FLAER-based WBC assay in the primary screening of PNH clones.
        Am J Clin Pathol. 2009; 132: 564-572
        • Dalal B.I.
        • Khare N.S.
        Flow cytometric testing for paroxysmal nocturnal hemoglobinuria: CD64 is better for gating monocytes than CD33.
        Cytometry B Clin Cytom. 2013; 84: 33-36
        • Sutherland D.R.
        • Acton E.
        • Keeney M.
        • et al.
        Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detection.
        Cytometry B Clin Cytom. 2014; 86: 44-55
        • Hernandez-Campo P.M.
        • Almeida J.
        • Acevedo M.J.
        • et al.
        Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria.
        Transfusion. 2008; 48: 1403-1414
        • Sutherland D.R.
        • Illingworth A.
        • Keeney M.
        • et al.
        High-sensitivity detection of PNH red blood cells, red cell precursors, and white blood cells.
        Curr Protoc Cytom. 2015; 72 (6.37.1-30)
        • ICSH/ICCS Workgroup
        Validation of cell-based fluorescence assays: practice guidelines from the International Council for Standardization of Haematology and International Clinical Cytometry Society.
        Cytometry B Clin Cytom. 2013; 84: 281
        • Hu R.
        • Mukhina G.L.
        • Piantadosi S.
        • et al.
        PIG-A mutations in normal hematopoiesis.
        Blood. 2005; 105: 3848-3854
        • Davis B.H.
        • McLaren C.E.
        • Carcio A.J.
        • et al.
        Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical method.
        Cytometry B Clin Cytom. 2013; 84: 329-337
        • Davis B.H.
        • Keeney M.
        • Brown R.
        • et al.
        2nd edition. H52–A2 red blood cell diagnostic testing using flow cytometry; approved guideline. vol. 34. Clinical and Laboratory Standards Institute, Wayne (PA)2014
        • Fletcher M.
        • Sutherland D.R.
        • Whitby L.
        • et al.
        Standardizing leucocyte PNH clone detection: an international study.
        Cytometry B Clin Cytom. 2014; 86: 311-318
        • Marinov I.
        • Kohoutova M.
        • Tkacova V.
        • et al.
        Intra- and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 practical guidelines for high-sensitivity paroxysmal nocturnal hemoglobinuria testing.
        Cytometry B Clin Cytom. 2013; 84: 229-236